TPG-backed Aptalis Pharma hires banks for an IPO

Aptalis Pharma Inc, a specialty drugmaker owned by private equity firm TPG Capital LP, has appointed underwriters for an initial public offering after efforts to sell the company failed, people familiar with the matter told sister news service Reuters.